CHNC .0002 Acquisition of Precision Research

New Post Public Reply Private Reply Replies (1) Message Board
FLA
164
CHNC .0002 Acquisition of Precision Research Institute


All Content and Data provided by Third-Parties — Terms of Use
China Infrastructure Construction Corp. (OTCPK: CHNC) is Pleased to Announce its Acquisition of Precision Research Institute, LLC (PRI)
GLOBENEWSWIRE 8:00 AM ET 10/21/2019
Symbol Last Price Change
CHNC 0.0002down 0 (0%)
QUOTES AS OF 03:56:34 PM ET 10/18/2019
HOUSTON, TX, Oct. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – China Infrastructure Construction Corp.(CHNC) www.chnc-hdh.com is pleased to announce its acquisition of Precision Research Institute, LLC (PRI).

PRI is a Multi-Therapeutic, Dedicated Research Unit based in Houston, Texas. PRI brings multi-million-dollar contracts with the largest pharmaceutical companies in the world--like Abbvie, Samumed, Gilead, Intercept, Shire Pharmaceuticals, and more. President & CEO Elizabeth Hernandez says, “This acquisition of PRI, our second in the past year, now puts CHNC in the unique position of conducting its own clinical research trials. Which holds an important value the to the future of Medicine. CHNC is now in position to be the leader in the arena of Medical Clinical Trials. CHNC is in the process of becoming its very own Contract Research Organization (CRO) in the Industry. The looking forward to developing the future of Pharmaceutical, Biotechnology, and Pharmacovigilance Clinical Trials. PRI has Phase I, II, and III clinical trial capabilities--a rare feat. PRI’s facility is 4500 sq. ft. and currently has ongoing Phase II, III clinical trials, along with observational studies. Their fifteen active multi-million-dollar contracts is a great head start for CHNC. We look forward to expanding quickly!”

The acquisition, which has been approved by the board of directors, is subject to certain closing conditions, including OTC approval, approval by the stockholders of China Infrastructure Construction Corp.(CHNC) , minimum cash balance of CHNC at closing, and other customary closing conditions.

About China Infrastructure Construction Corp.(CHNC)

Hippocrates Direct Healthcare, Inc. is a wholly owned subsidiary of CHNC, maintains a medical office, and also does clinical research for pharmaceutical companies. Hippocrates began with its membership-based model and now provides stem cell and clinical research services.

Hippocrates Direct Healthcare, Inc. is a wholly-owned subsidiary of China Infrastructure (OTCPK: CHNC). China Infrastructure's common stock trades on the OTC Markets under the ticker symbol "CHNC."

Safe Harbor Statement

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.

Hippocrates Direct Healthcare™ and the Hippocrates Direct Healthcare™ logo are all trademarks or registered trademarks of Hippocrates Direct Healthcare™, Inc.

CONTACTS:
Investors:
Hippocrates Direct Healthcare™, Inc.
Elizabeth@chnc-hdh.com
832-606-7500

Media:
Elizabeth@chnc-hdh.com

Image: China Inf..png


Source: China Infrastructure Construction Corp.(CHNC)
2019 GlobeNewswire, Inc.


















CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC CHNC
I ONLY POST WHAT I PLAY
Scroll down for more posts ▼

Top 10 Most Recent News Articles

RELISH 2026: Orange County's Ultimate Food & Drink Bash

Updated Category News Views 1

A Festival Like No Other If there’s anything Orange County knows how to do, it’s throw a party. And here comes RELISH, a three-day feast for the senses that’ll have foodies talking for weeks. Organized by Celebrity Chef Jamie Gwen and Event Planner Nicole Hirsty, this is not your average town fair. This is indulgence on a silver platter, set to take place from...

Continue Reading
VIN Foundation's Generous Push for Vet Education in 2027

Updated Category News Views 3

Scholarships Fueling Future Veterinarians Not a day goes by without someone singing the praises of VIN Foundation's efforts. This time, they're spotlighting two fresh souls embarking on their vet school journey. Mark it, folks, the 2027 Mike Dunn, DVM Veterinary Student Scholarship, birthed by Becky Godchaux, is here to soften the financial blow. Up to $140,000 per head...

Continue Reading
Enovis' Acquisition of eCential Robotics: A Game-Changer

Updated Category News Views 4

Is Enovis Making a Smart Move with eCential Robotics? Alright, folks. Here's the lowdown from a seasoned old-timer in this wild market playground. Enovis Corporation, the NYSE:ENOV ticker you've been seeing, decided to put on its big boy pants and go after eCential Robotics. This French-born player is all about surgical robotics and enabling tech—just the sort of...

Continue Reading
Phoenix Initiative Delivers Meals, Health Aid Downtown

Updated Category News Views 5

Phoenix's Fight Against Homelessness Gets Personal When you hit the streets of downtown Phoenix on a scorching Saturday morning, you're not just encountering sweltering heat; you're witnessing compassion in motion. An unexpected coalition has emerged, unraveling the web of homelessness in the heart of Arizona. Forget the stock tips, this one’s about community fortitude....

Continue Reading
Manulife's $750M US Offering: Risky or Strategic?

Updated Category News Views 2

Manulife: Debuting $750M in Subordinated Notes When it comes to Manulife's latest move, it's all about the numbers. They've priced a U.S. public offering of a meaty $750 million in subordinated notes at an enticing 6.146% interest rate. That's no pocket change, folks, and it highlights a strategy or a gamble, depending on your view. But here's the kicker: these notes may...

Continue Reading
ZERO Fresh Start: RAVEN2's New Era Begins Sept 15

Updated Category News Views 2

What's the Big Deal with ZERO? Alright, so here we go, folks—Netmarble's strapping in with their latest server for RAVEN2, and it's called ZERO. Ever heard of fresh starts? ZERO is exactly that. This isn't your usual server shuffle. Lads and ladies who've felt the grind’ll tell you, ZERO's introducing a slew of changes you might want to sit up for. Pre-registration's...

Continue Reading
Youlife Partners for Vocational Training in Ji'an

Updated Category News Views 4

Big Moves in Education for Youlife Youlife Group Inc., the bigwig in China's blue-collar work scene, just inked a strategic pact that's worth a second look—or several. Teaming up with Ji'an Industry-Education Integration Technology Co., Ltd., they've got a plan to turn heads and maybe some profit margins too. This isn't just about signing papers; it's about forging a...

Continue Reading
Zepp Health's Q2 2026 Results: Growth Amid Struggles

Updated Category News Views 1

Revenue Growth, Yet the Road Is Rocky Buckle up, investors, because Zepp Health Corporation's (NYSE: ZEPP) latest financials are a bit of a mixed salad—there's some good and some bad tossed in. Reporting a revenue of $63.5 million for the second quarter of 2026, the company managed to eke out a 6.9% increase year-over-year. But before you pop the champagne, let's dig a...

Continue Reading
AB 2529: New Bill Awaits Governor's Decision

Updated Category News Views 1

Legislative Milestone or Just Another Step? Hidden Hills, California is causing a bit of a ripple in the state's legislative waters with Assembly Bill 2529. Now that the bill has sailed through the California Legislature with impressive bipartisan support—it passed the State Senate 39-0 and the Assembly 62-4—it's sitting pretty on the Governor's desk. The question...

Continue Reading
Subtle Cosmetic Dentistry Transformations Boost Confidence

Updated Category News Views 2

Rethinking Cosmetic Dentistry: Small Changes, Big Impact Listen up, folks. Turns out, it's the little tweaks that make your grin shine, not an expensive overhaul. This little nugget comes straight from the mouth of Dr. Jared Giatras at Giatras Family Dentistry, Murfreesboro. The old-school perception that you need to wipe the slate clean and start fresh with a chiclet...

Continue Reading

Top 5 Most Recently Viewed Articles

Adial Pharmaceuticals Advances AD04 Following FDA Meeting

Updated Category News Views 217

Positive Developments for Adial Pharmaceuticals and AD04 Adial Pharmaceuticals, Inc. (NASDAQ: ADIL), a biopharmaceutical company dedicated to addressing addiction and related disorders, recently received significant updates from its End of Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA). This meeting, which was held to discuss the development of...

Continue Reading
Tradr Unveils Innovative 2X Leveraged ETFs for Quantum Stocks

Updated Category News Views 153

Exciting New ETFs from Tradr ETFs Tradr ETFs has just launched innovative financial products that cater specifically to traders keen on quantum computing technology. Among the new offerings are the Tradr 2X Long QUBT Daily ETF and the Tradr 2X Long RGTI Daily ETF. These funds are designed to provide traders with 200% daily exposure to Quantum Computing Inc. (NASDAQ: QUBT)...

Continue Reading
36Kr Holdings Inc. Launches European Central Station Initiative

Updated Category News Views 185

36Kr Holdings Inc. (NASDAQ: KRKR) made waves back in 2024 by launching the 36Kr European Central Station, a bold move aimed at expanding its foothold in the global market. The chatter around this initiative was palpable as traders eyed how this could reshape connections between Chinese startups and international players. You had to wonder—would it just be another flash...

Continue Reading
Apple's Leadership Changes and Upcoming Innovations Unveiled

Updated Category News Views 228

Apple's Recent Executive Changes Impacting the Tech Giant This past week brought forth noteworthy changes and developments at Apple Inc. (NASDAQ: AAPL), illustrating the company’s adaptability in a fast-evolving technology landscape. From potential executive exits to a shift in operational strategies, Apple is poised for significant transformations that aim to...

Continue Reading
Experian Dividend Exchange Rate Announcement and Key Details

Updated Category News Views 157

Experian Announces Dividend Exchange Rate Experian (OTC: EXPGF), a prominent global information services provider, has recently announced the exchange rate for its forthcoming first interim dividend. This dividend payment, which is set at 19.25 US cents per share, presents an excellent opportunity for investors. It is crucial for shareholders to take note of the details...

Continue Reading